A predictive model based on site-specific risk factors of recurrence regions in endometrial cancer patients

被引:1
作者
Shin, Wonkyo [1 ,2 ]
Yang, Seong J. [3 ]
Park, Sang-Yoon [1 ]
Kang, Sokbom [1 ]
Lee, Dong Ock [1 ]
Lim, Myong Cheol [1 ]
Seo, Sang-Soo [1 ,4 ]
机构
[1] Natl Canc Ctr, Ctr Gynecol Canc, Goyang, South Korea
[2] Chungnam Natl Univ, Dept Obstet & Gynecol, Sejong Hosp, Sejong, South Korea
[3] Jeonbuk Natl Univ, Dept Stat, Inst Appl Stat, Jeonju, South Korea
[4] Natl Canc Ctr, 323 Ilsan Ro, Goyang Si 10408, Gyeonggi Do, South Korea
关键词
Endometrial cancer; Lymph node; Lymph node dissection; Survival rate; PROGNOSTIC-SIGNIFICANCE; OVARIAN PRESERVATION; MYOMETRIAL INVASION; WOMEN; INTERMEDIATE; RADIATION; THERAPY;
D O I
10.1186/s12885-022-10193-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective This study investigated site-specific differences in clinical factors for recurrence in patients who were newly diagnosed and treated for endometrial cancer. A model for predicting recurrence sites was generated. Methods Electronic medical records' data were retrieved from January 2006 to December 2018 for patients who were diagnosed with endometrial cancer at the National cancer center in Korea. Recurrence sites were classified as local, regional, or distant. We used multinomial logistic regression models that modeled the log-odds for the three recurrence sites relative to non-recurrence as a linear combination of possible risk factors for the recurrence of endometrial cancer. Results The data of 611 patients were selected for analysis; there were 20, 12, and 25 cases of local, regional, and distant recurrence, respectively, and 554 patients had no recurrence. High-grade disease was associated with local recurrence; non-endometrioid histology and parametrial invasion were risk factors for regional recurrence; additionally, parametrial invasion and no lymphadenectomy were associated with distant metastasis. Conclusion We identified different risk factors specific for each type of recurrence site. Using these risk factors, we suggest that individually tailored adjuvant treatments be introduced for patients.
引用
收藏
页数:8
相关论文
共 29 条
  • [1] Abu-Rustum Nadeem R, 2021, J Natl Compr Canc Netw, V19, P888, DOI 10.6004/jnccn.2021.0038
  • [2] Colombo N, ESMO ESGO ESTRO CONS, P1569
  • [3] Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Petronella B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    D'Amico, Romerai
    Fyles, Anthony
    Baron, Marie-Helene
    Jurgenliemk-Schulz, Ina M.
    Kitchener, Henry C.
    Nijman, Hans W.
    Wilson, Godfrey
    Brooks, Susan
    Gribaudo, Sergio
    Provencher, Diane
    Hanzen, Chantal
    Kruitwagen, Roy F.
    Smit, Vincent T. H. B. M.
    Singh, Naveena
    Do, Viet
    Lissoni, Andrea
    Nout, Remi A.
    Feeney, Amanda
    Verhoeven-Adema, Karen W.
    Putter, Hein
    Creutzberg, Carien L.
    [J]. LANCET ONCOLOGY, 2019, 20 (09) : 1273 - 1285
  • [4] Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study
    Falcone, Francesca
    Maggiore, Umberto Leone Roberti
    Di Donato, Violante
    Perrone, Anna Myriam
    Frigerio, Luigi
    Bifulco, Giuseppe
    Polterauer, Stephan
    Casadio, Paolo
    Cormio, Gennaro
    Masciullo, Valeria
    Malzoni, Mario
    Greggi, Stefano
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (05) : 1 - 13
  • [5] Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer
    Falcone, Francesca
    Laurelli, Giuseppe
    Losito, Simona
    Di Napoli, Marilena
    Granata, Vincenza
    Greggi, Stefano
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2017, 28 (01)
  • [6] Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%
    Geels, Y. P.
    Pijnenborg, J. M. A.
    van den Berg-van Erp, S. H. M.
    Snijders, M. P. M. L.
    Bulten, J.
    Massuger, L. F. A. G.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 129 (02) : 285 - 291
  • [7] Hosmer DWaL S., 1989, APPL LOGISTIC REGRES
  • [8] Kim MK, 2019, J GYNECOL ONCOL, V30, DOI [10.3802/jgo.2019.30.e47, 10.35736/JCS.30.2.1]
  • [9] Prognostic significance of gross myometrial invasion with endometrial cancer
    Larson, DM
    Connor, GP
    Broste, SK
    Krawisz, BR
    Johnson, KK
    [J]. OBSTETRICS AND GYNECOLOGY, 1996, 88 (03) : 394 - 398
  • [10] Long-Term Oncologic and Reproductive Outcomes in Young Women With Early Endometrial Cancer Conservatively Treated A Prospective Study and Literature Update
    Laurelli, Giuseppe
    Falcone, Francesca
    Gallo, Maria Stella
    Scala, Felice
    Losito, Simona
    Granata, Vincenza
    Cascella, Marco
    Greggi, Stefano
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (09) : 1650 - 1657